- cafead   May 29, 2024 at 11:52: AM
via COVID-19 vaccine maker BioNTech (22UAy.DE) has secured up to $145 million in funding from a global coalition against infectious diseases to help build a production network in Africa for shots based on cutting-edge messenger-RNA (mRNA) technology.
article source
article source